ST-2427 / SiteOne Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ST-2427 / SiteOne Therap
NCT04475198: Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427

Terminated
1
24
US
ST-2427, Placebo
SiteOne Therapeutics, Inc., National Institute on Drug Abuse (NIDA)
Acute, Post-operative Pain
08/21
08/21

Download Options